ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01384253
Recruitment Status : Completed
First Posted : June 29, 2011
Last Update Posted : September 30, 2016
Sponsor:
Information provided by (Responsible Party):
Orano Med LLC